# Spero Therapeutics, Inc.: Form 8-K, filed Jan 19, 2021

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2021-01-19
- Accepted by EDGAR: Jan 19, 2021, 08:01 ET
- Period: 2021-01-15
- Accession: 0001193125-21-010857
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312521010857/d64288d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312521010857/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312521010857/d64288d8k.htm

Filed Jan 19, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-010857. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
